Sal's Investment Syndicate: Click to Join

Harvard’s Tom Eisenmann is the author of Why Startups Fail: A New Roadmap for Entrepreneurial Success. We discussed valuable lessons from the book and how they might apply to biotech startups.

Highlights:

• Sal Daher Introduces Prof. Tom Eisenmann of the Harvard Business School, Author of Why Startups Fail
• Howard Stevenson’s 400X Return
• Contrasting Brad Feld’s Book with Prof. Tom Eisenmann’s Book
• Sal Daher’s Favorite Part of the Book: Failing
• “[failed] founders probably cycle through those. ...the Kubler Ross stages...”
• “...basically, half of failed founders come back and get back on the horse and do it again.”
• Shutting Down the Failed Venture, Gracefully
• The Number One Killer of Startups: False Starts
• “...engineers are particularly vulnerable to this because they want to build.”
• Sal Daher Discusses SQZ Biotech’s False Start and Brilliant Pivot
• The Origin Story of Why Startups Fail
• “...the factories that actually make this stuff actually generate enough cash to invest in new apparel companies...”
• Silver Linings of the Pandemic
• Tom Eisenmann on Harvard’s School of Engineering and the MS/MBA Program
• Tom Eisenmann on Tough Tech: Technical Uncertainty + Market Uncertainty
• Creating Supports for Life Science Academics to Become Founders
• Creative Destruction Labs
• Sal Daher’s Focus on Biotech Angel Formation
• Software Startup Funding vs. Biotech Startup Funding
• Maybe Successful Angel-Backed Founders Such as Todd Zion and Armon Sharei Could be a Resource for Training Angels
• The Dynamics of Venture Capital in the Last Decade – Many New Shoots
• Tom Eisenmann’s Parting Thoughts

Sponsored by:

• Purdue University entrepreneurship, and
• Peter Fasse, patent attorney at Fish & Richardson

Topics: biotech, management, co-founders, Mass Challenge, raising money, scholar, venture capital